Open AccessProstate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
Author(s) -
Reginald W Dusing,
Warner Peng,
Sue Min Lai,
Gordon L. Grado,
Jeffrey M. Holzbeierlein,
J. Brantley Thrasher,
John L. Hill,
Peter J. Van Veldhuizen
Publication year - 2014
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000000516
Subject(s) - medicine , prostate specific antigen , prostate cancer , glutamate carboxypeptidase ii , prostate , antigen , urology , oncology , cancer , pca3 , nuclear medicine , immunology
The aim of this study was to identify which patient characteristics are associated with the highest likelihood of positive findings on 11C-acetate PET/computed tomography attenuation correction (CTAC) (PET/CTAC) scan when imaging for recurrent prostate cancer.